Impact of disrupting adenosine A 3 receptors (A 3 -/-AR) on colonic motility or progression of colitis in the mouse

Inflammatory Bowel Diseases

Volumn 17, Issue 8, 2011, Pages 1698-1713

  Ren, Tianhua ^a   Grants, Iveta ^a   Alhaj, Mazin ^a   McKiernan, Matt ^a   Jacobson, Marlene ^b   Hassanain, Hamdy H ^a   Frankel, Wendy ^c   Wunderlich, Jacqueline ^a   Christofi, Fievos L ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

A3 AR mouse; adenosine receptors; enteric nervous system; gliotransmission; motility; murine DSS colitis; presynaptic inhibitory A 3AR

Indexed keywords

ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR ANTIBODY; ANTISERUM; DEXTRAN SULFATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GUAIAC; MYELOPEROXIDASE; PROTEIN S 100; RECEPTOR ANTIBODY; TRYPTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANUS CONTINENCE; ARTICLE; ASCENDING COLON; CD4+ T LYMPHOCYTE; COLITIS; COLON; COLON LENGTH; COLON MOTILITY; COLON MUCOSA; COMPARATIVE STUDY; CONTROLLED STUDY; CRYPT CELL; DEFECATION; DESCENDING COLON; DIARRHEA; DISEASE COURSE; FEMALE; GENOTYPE; GLIA; HISTOPATHOLOGY; IMMUNOCHEMISTRY; IMMUNOGENICITY; IMMUNOREACTIVITY; IN VIVO STUDY; INTESTINE INNERVATION; INTESTINE TRANSIT TIME; KNOCKOUT MOUSE; LYMPHOCYTIC INFILTRATION; MOUSE; MUSCLE CELL; MYENTERIC PLEXUS; NERVE; NEUROTRANSMISSION; NEUTROPHIL; NONHUMAN; OCCULT BLOOD; PHENOTYPE; POLYMERASE CHAIN REACTION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; SPLEEN WEIGHT; VARICOSIS; WEIGHT REDUCTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; CD4 LYMPHOCYTE COUNT; COLITIS; COLON; DEFECATION; DEXTRAN SULFATE; DIARRHEA; FEMALE; GASTROINTESTINAL TRANSIT; GENOTYPE; MICE; MICE, KNOCKOUT; MYENTERIC PLEXUS; OCCULT BLOOD; ORGAN SIZE; PEROXIDASE; RECEPTOR, ADENOSINE A3; SPLEEN; TIME FACTORS; WEIGHT LOSS;

EID: 79960248344     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21553     Document Type: Article

References (62)

1. Christofi FL., Unlocking mysteries of gut sensory transmission: is adenosine the key? News Physiol Sci. 2001; 16: 201-207. (Pubitemid 33712824)
2. Christofi FL., Purinergic receptors and gastrointestinal secretomotor function. Purinergic Signal. 2008; 4: 213-236.
3. Dixon AK, Gubitz AK, Sirinathsinghji DJ, et al. Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol. 1996; 118: 1461-1468. (Pubitemid 26248800)
4. Christofi FL, Zhang H, Yu JG, Guzman J, et al. Differential gene expression of adenosine A1, A2a, A2b, and A3 receptors in the human enteric nervous system. J Comp Neurol. 2001; 439: 46-64.
5. Deshpande NA, McDonald TJ, Cooke MA., Endogenous interstitial adenosine in isolated myenteric neural networks varies inversely with prevailing P02. Am J Physiol Gastrointest Liver Physiol. 1999; 276: G875-G885. (Pubitemid 29214100)
6. Christofi FL, Kim M, Wunderlich JE, et al. Endogenous adenosine differentially modulates 5-hydroxytryptamine from a human enterochromaffin cell model. Gastroenterology. 2004; 127: 188-202. (Pubitemid 38962287)
7. Wunderlich JE, Needleman BJ, Chen Z, et al. Dual purinergic synaptic transmission in the human enteric nervous system. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G554-G566. (Pubitemid 351253340)
8. Baggott JE, Morgan SL, Ha TS, et al. Antifolates in rheumatoid arthritis: a hypothetical mechanism of action. Clin Exp Rheumatol. 1993; 11: S101-S105. (Pubitemid 23136906)
9. Ralevic V, Burnstock G., Receptors for purines and pyrimidines. Pharmacol Rev. 1998; 50: 413-492. (Pubitemid 28477681)
10. Martin C, Leone M, Viviand X, et al. High adenosine plasma concentration as a prognostic index for outcome in patients with septic shock. Crit Care Med. 2000; 28: 3198-3202.
11. Sperlagh B, Doda M, Baranyi M, et al. Ischemic-like condition releases norepinephrine and purines from different sources in superfused rat spleen strips. J Neuroimmunol. 2000; 111: 45-54.
12. Sottofattori E, Anzaldi M, Ottonello L., HPLC determination of adenosine in human synovial fluid. J Pharm Biomed Anal. 2001; 24: 1143-1146. (Pubitemid 32209175)
13. Hasko G, Cronstein BN., Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 2004; 25: 33-39. (Pubitemid 38032805)
14. Cronstein BN, Naime D, Ostad E., The anti-inflammatory mechanism of methotrexate: increased adenosine release at inflamed sites diminished leukocyte accumulation in an in vivo model of inflammation. J Clin Invest. 1993; 92: 2675-2682. (Pubitemid 24006532)
15. Cronstein B, Naime D, Firestein G., The anti-inflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum. 1995; 38: 1040-1045.
16. Siegmund B, Rieder F, Albrich S, et al. Adenosine kinase inhibitor GP515 improves experimental colitis in mice. JPET. 2001; 296: 99-105. (Pubitemid 32015066)
17. Mabley J, Soriano F, Pacher P, et al. The adenosine A3 receptor agonist, N6-(3-iodobenyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. Eur J Pharmacol. 2003; 466: 323-329. (Pubitemid 36412095)
18. Guzman J, Yu JG, Suntres Z, et al. ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis. Inflamm Bowel Dis. 2006; 12: 766-789. (Pubitemid 44253762)
19. Antonioli L, Fornai M, Colucci R, et al. Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflamm Bowel Dis. 2008; 14: 566-574. (Pubitemid 351571838)
20. Cavalcante IC, Castro MV, Barreto AR, et al. Effect of novel A2A adenosine receptor agonist ATL 313 on Clostridium difficile toxin A-induced murine ileal enteritis. Infect Immun. 2006; 74: 2606-2612. (Pubitemid 43672968)
21. Naganuma M, Wiznerowicz EB, Lappas CM, et al. Cutting edge: critical role for A2A adenosine receptors in the T-cell-mediated regulation of colitis. J Immunol. 2006; 177: 2765-2769. (Pubitemid 44277790)
22. Odashima M, Bamias G, Rivera-Nieves J, et al. Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease. Gastroenterology. 2005; 129: 26-33. (Pubitemid 41002039)
23. Kolachala VL, Vijay-Kumar M, Dalmasso G, et al. A2B adenosine receptor gene deletion attenuates murine colitis. Gastroenterology. 2008; 135: 861-870.
24. Van Troostenburg AR, Clark EV, Carey WD, et al. Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men. Int J Clin Pharmacol Ther. 2004; 42: 434-442.
25. Fishman P, Bar-Yehuda S, Madi L, et al. The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Arthritis Res Ther. 2006; 8: R33.
26. Guo Y, Bolli R, Bao W, et al. Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning. J Mol Cell Cardiol. 2001; 33: 825-830. (Pubitemid 32538994)
27. Von Lubitz DK, Lin RC, Popik P, et al. Adenosine A3 receptor stimulation and cerebral ischemia. Eur J Pharmacol. 1994; 263: 59-67.
28. Von Lubitz DK, Simpson KL, Lin RC., Right thing at a wrong time? Adenosine A3 receptors and cerebroprotection in stroke. Ann N Y Acad Sci. 2001; 939: 85-96. (Pubitemid 32621718)
29. Zheng J, Wang R, Zambraski E, et al. Protective roles of adenosine A1, A2A, and A3 receptors in skeletal muscle ischemia and reperfusion injury. Am J Physiol Heart Circ Physiol. 2007; 293: H3685-6891.
30. Cooke HJ, Javed N, Christofi FL., Enteric neural reflexes and secretion. In:, Goetzl EJ, Blennerhassett MG, Bienestock J, editors. Autonomic nervous system, autonomic neuroimmunology. Vol. 16. Reading, UK: Hardwood Academic; 2003: 35-59.
31. De Man JG, Seerden TC, De Winter BY, et al. Alteration of the purinergic modulation of enteric neurotransmission in the mouse ileum during chronic intestinal inflammation. Br J Pharmacol. 2003; 139: 172-184. (Pubitemid 36645321)
32. Bozarov A, Wang YZ, Yu JG, et al. Activation of adenosine low-affinity A3 receptors inhibits the enteric short interplexus neural circuit triggered by histamine. Am J Physiol Gastrointest Liver Physiol. 2009; 297: G1147-G1162.
33. Salvatore CA, Tilley SL, Latour AM, et al. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. J Biol Chem. 2000; 275: 4429-4434. (Pubitemid 30094686)
34. Cooke HJ, Xue J, Yu JG, et al. Mechanical stimulation releases nucleotides that activate P2Y1 Rs to trigger neural reflex chloride secretion in guinea pig distal colon. J Comp Neurol. 2004; 469: 1-15. (Pubitemid 38036890)
35. Castaneda FE, Walia B, Vijay-Kumar M, et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology. 2005; 129: 1991-2008. (Pubitemid 41772976)
36. Miller MS, Galligan JJ, Burks TF., Accurate measurement of intestinal transit in the rat. J Pharmacol Methods. 1981; 6: 211-217. (Pubitemid 12196372)
37. Kabashima K, Saji T, Murata T, et al. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut. J Clin Invest. 2002; 109: 883-893. (Pubitemid 34275109)
38. Cremon C, Gargano L, Morselli-Labate AM, et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol. 2009; 104: 392-400.
39. Rybaczyk L, Rozmiarek A, Circle K, et al. A new bioinformatics approach to analyze gene expressions and signaling pathways reveals unique purine gene dysregulation profiles that distinguish between CD and UC. Inflamm Bowel Dis. 2009; 15: 971-984.
40. Appel E, Kazimirsky G, Ashkenazi E, et al. Roles of BCL-2 and caspase 3 in the adenosine A3 receptor-induced apoptosis. J Mol Neurosci. 2001; 7: 285-292. (Pubitemid 34123945)
41. Von Lubitz DK, Carter MF, Deutsch SI, et al. The effects of adenosine A3 receptor stimulation on seizures in mice. Eur J Pharmacol. 1995; 275: 23-29.
42. Smith SR, Denhardt G, Terminelli C., A role for histamine in cytokine modulation by the adenosine A(3) receptor agonist, 2-Cl-IB-MECA. Eur J Pharmacol. 2002; 457: 57-69. (Pubitemid 35379976)
43. Ramkumar V, Stiles GL, Beaven MA, Ali H., The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem. 1993; 268: 16887-16890. (Pubitemid 23236909)
44. Chandrasekharan BP, Kolachala VL, Dalmasso G, et al. Adenosine 2B receptors (A(2B)AR) on enteric neurons regulate murine distal colonic motility. FASEB J. 2009; 23: 2727-2734.
45. Hart ML, Much C, Gorzolla IC, et al. Extracellular adenosine production by ecto-5'-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology. 2008; 135: 1739-1750.
46. Beldi G, Wu Y, Sun X, et al. Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration. Gastroenterology. 2008; 135: 1751-1760.
47. Firestein G, Boyle D, Bullough D, et al. Protective effect of an adenosine kinase inhibitor in septic shock. J Immunol. 1994; 152: 5853-5859. (Pubitemid 24174165)
48. Marak GE Jr, de Kozak Y, Faure JP, et al. Pharmacologic modulation of acute ocular inflammation. I. Adenosine. Ophthalmic Res. 1988; 20: 220-226.
49. Rosengren S, Bong G, Firestein GS., Anti-inflammatory effects of an adenosine kinase inhibitor: decreased neutrophil accumulation and vascular leakage. J Immunol. 1995; 154: 5444-5451.
50. Cronstein BN, Van de Strouwe M, Druska L, et al. Nonsteroidal anti-inflammatory agents inhibit stimulated neutrophil adhesion to endothelium: adenosine dependent and independent mechanisms. Inflammation. 1994; 18: 323-335. (Pubitemid 24232684)
51. Sharkey, KA, Kroese A., Consequences of intestinal inflammation on the enteric nervous system: neuronal activation induced by inflammatory mediators. Anat Rec. 2001; 262: 79-90. (Pubitemid 32061916)
52. Wunderlich JE, Ren T, Needleman BJ, et al. Novel purinergic P1, P2X and P2Y receptor signaling targets in the human enteric nervous system and glia. Gastroenterology. 2009; 136 (suppl 1): A-3.
53. Abbracchio MP, Burnstock G, Verkhratsky A, et al. Purinergic signalling in the nervous system: an overview. Trends Neurosci. 2008; 32: 19-29.
54. Rühl A, Nasser Y, Sharkey KA., Enteric glia. Neurogastroenterol Motil. 2004; 16 (suppl 1): 44-49. (Pubitemid 38580940)
55. Camilleri M., Motor function in irritable bowel syndrome. Can J Gastroenterol. 1999; 13 (suppl A): 8A-11A.
56. Hansen MB., The enteric nervous system. II. Gastrointestinal functions. Pharmacol Toxicol. 2003; 92: 249-257. (Pubitemid 36734982)
57. Seidler U, Lenzen H, Cinar A, et al. Molecular mechanisms of disturbed electrolyte transport in intestinal inflammation. Ann N Y Acad Sci. 2006; 1072: 262-275. (Pubitemid 44448459)
58. Ochaion A, Bar-Yehuda S, Cohen S, et al. The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol. 2009; 258: 115-122.
59. Gessi S, Cattabriga E, Avitabile A, et al. Elevated expression of A3 adenosine receptors in human colorectal cancer is reflected in peripheral blood cells. Clin Cancer Res. 2004; 10: 5895-5901. (Pubitemid 39180971)
60. Spruntulis LM, Broadley KJ., A3 receptors mediate rapid inflammatory cell influx into the lungs of sensitized guinea-pigs. Clin Exp Allergy. 2001; 31: 943-951. (Pubitemid 34204269)
61. Walker BAM, Jacobson MA, Knight DA, et al. Adenosine A3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol. 1997; 16: 531-537. (Pubitemid 127498285)
62. Barczyk K, Ehrchen J, Tenbrock K, et. al. Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. Blood. 2010; 116: 446-455.